GlassScriptPhysician profile
Tanmay V Swadia
NPI 1265694426
$2,669.24
in general payments reported to CMS, 2019-2025
24 companies · $428 in 2025
The $428 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.84 · 2020: $169 · 2021: $855 · 2022: $303 · 2023: $351 · 2024: $477 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $772.84 | 2020-2025 | Watchman Flx, Ekosonic, Avvigo Guidance System |
| Penumbra, INC. | $767.79 | 2021 | |
| Abbott Laboratories | $308.79 | 2020-2025 | Perclose Prostyle, Perclose Proglide, Jeti Peripheral Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.61 | 2024-2025 | Lifevest |
| Cordis US Corp. | $106.57 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Inari Medical, INC. | $105.12 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abiomed | $57.93 | 2021-2025 | |
| Amgen INC. | $49.57 | 2019-2024 | Repatha |
| Medtronic, INC. | $44.78 | 2022-2025 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $31.52 | 2022-2025 | Eliquis |
| Lantheus Medical Imaging, INC. | $28.45 | 2022 | |
| Ekos Corporation | $26.78 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $25.05 | 2024 | Arcalyst |
| Biosense Webster, INC. | $24.44 | 2025 | Nuvision Ice Catheter |
| Kestra Medical Technology Services, INC. | $21.86 | 2023 | Assure Wcd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $21.03 | 2022 | |
| Cardiva Medical, INC. | $20.23 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.03 | 2024 | |
| Teleflex LLC | $19.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.40 | 2019 | |
| Shockwave Medical, INC | $14.98 | 2022 | |
| Cardiovascular Systems INC. | $14.48 | 2019 | |
| Pfizer INC. | $14.00 | 2019 | |
| Cathworks, INC. | $13.76 | 2025 | Ffrangio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanmay Swadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.